Combination therapy with CC-5013 (Lenalidomide; Revlimid™) plus dexamethasone (Rev/Dex) for newly diagnosed myeloma (MM).

被引：0
|
作者：
Rajkumar, SV
Hayman, SR
Lacy, MQ
Dispenzieri, A
Hoering, A
Geyer, SM
Zeldenrust, SR
Greipp, PR
Fonseca, R
Lust, JA
Russell, SJ
Kyle, RA
Witzig, TE
Gertz, MA
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Div Biostat, Rochester, MN USA
[3] Mayo Clin, Div Hematol Oncol, Scottsdale, AZ USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
331
引用
收藏
页码：98A / 98A
页数：1
相关论文
共 50 条
  • [1] Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
    Rajkumar, SV
    Hayman, SR
    Lacy, MQ
    Dispenzieri, A
    Geyer, SM
    Kabat, B
    Zeldenrust, SR
    Kumar, S
    Greipp, PR
    Fonseca, R
    Lust, JA
    Russell, SJ
    Kyle, RA
    Witzig, TE
    Gertz, MA
    [J]. BLOOD, 2005, 106 (13) : 4050 - 4053
  • [2] Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.
    Rajkumar, SV
    Hayman, S
    Lacy, MQ
    Dispenzieri, A
    Geyer, SM
    Kabat, B
    Zeldenrust, SR
    Kumar, S
    Greipp, PR
    Fonseca, R
    Lust, JA
    Russell, SJ
    Kyle, RA
    Witzig, TE
    Gertz, MA
    [J]. BLOOD, 2005, 106 (11) : 230A - 231A
  • [3] Combination therapy with thalidomide plus dexamethasone (THAL/DEX) for newly diagnosed myeloma (MM).
    Rajkumar, SV
    Hayman, SR
    Gertz, MA
    Dispenzieri, A
    Lacy, M
    Greipp, PR
    Geyer, S
    Itturia, N
    Fonseca, R
    Lust, JA
    Kyle, R
    Witzig, TE
    [J]. BLOOD, 2001, 98 (11) : 849A - 849A
  • [4] Lenalidomide plus dexamethasone (Rev/Dex) in newly diagnosed myeloma: Response to therapy, time to progression, and survival.
    Lacy, Martha
    Gertz, Morie
    Dispenzieri, Angela
    Hayman, Suzanne
    Geyer, Susan
    Zeldenrust, Steven
    Kumar, Shaji
    Greipp, Philip
    Fonseca, Rafael
    Lust, John
    Russell, Stephen
    Kyle, Robert
    Witzig, Thomas
    Bergsagel, Leif
    Rajkumar, S. Vincent
    [J]. BLOOD, 2006, 108 (11) : 239A - 239A
  • [5] Combination of the mTOR inhibitor rapamycin and Revlimid™ (CC-5013) has synergistic activity in multiple myeloma (MM)
    Raje, N
    Kumar, S
    Hideshima, T
    Ishitsuka, K
    Chauhan, D
    Mitsiades, C
    Podar, K
    Le Gouill, S
    Richardson, P
    Munshi, NC
    Stirling, DI
    Antin, JH
    Anderson, KC
    [J]. BLOOD, 2004, 104 (11) : 417A - 417A
  • [6] Evaluation of protocol mandated testing in E4A03, a randomized phase III study of CC-5013 plus dexamethasone versus CC-5013 plus low-dose dexamethasone in multiple myeloma (MM).
    Callander, Natalie Scott
    Jacobus, Susanna J.
    Weiss, Matthias
    Kumar, Shaji
    Fonseca, Rafael
    Siegel, David Samuel DiCapua
    Katz, Michael S.
    Abonour, Rafat
    Williams, Michael E.
    Greipp, Philip R.
    Rajkumar, Vincent
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Lenalidomide plus dexamethasone effective in newly diagnosed myeloma
    Kate Matthews
    [J]. Nature Clinical Practice Oncology, 2006, 3 (3): : 116 - 117
  • [8] Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma
    Rajkumar, SV
    Hayman, S
    Gertz, MA
    Dispenzieri, A
    Lacy, MQ
    Greipp, PR
    Geyer, S
    Iturria, N
    Fonseca, R
    Lust, JA
    Kyle, RA
    Witzig, TE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (21) : 4319 - 4323
  • [9] Phase II Trial of Lenalidomide (Revlimid™) with Cyclophosphamide and Dexamethasone (RCd) for Newly Diagnosed Myeloma
    Kumar, Shaji
    Hayman, Suzanne
    Buadi, Francis
    Lacy, Martha
    Stewart, Keith
    Allred, Jacob
    Lauman, Kristina
    McCarty, Tammy
    Bergsagel, Leif
    Dingli, David
    Fonseca, Rafael
    Gertz, Morie
    Greipp, Philip
    Lust, John
    Russell, Stephen
    Reeder, Craig
    Wilzig, Thomas
    Zeldenrust, Steven
    Kyle, Robert
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    [J]. BLOOD, 2008, 112 (11) : 40 - 40
  • [10] Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
    Richardson, Paul G.
    Weller, Edie
    Lonial, Sagar
    Jakubowiak, Andrzej J.
    Jagannath, Sundar
    Raje, Noopur S.
    Avigan, David E.
    Xie, Wanling
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Mazumder, Amitabha
    Munshi, Nikhil C.
    Vesole, David H.
    Joyce, Robin
    Kaufman, Jonathan L.
    Doss, Deborah
    Warren, Diane L.
    Lunde, Laura E.
    Kaster, Sarah
    DeLaney, Carol
    Hideshima, Teru
    Mitsiades, Constantine S.
    Knight, Robert
    Esseltine, Dixie-Lee
    Anderson, Kenneth C.
    [J]. BLOOD, 2010, 116 (05) : 679 - 686
12345